Francesca Panin is a pharmacist with a PhD in Neuroscience. Her interests include pharmacology, neuroscience, sleep, drug addiction, genetics and regulatory/ethics for pre-clinical and clinical research. With a Fellowship of Higher Education Academy, Francesca supervises doctorate and research programmes.
Francesca is a pharmacist registered with the local GPhC and a neuropharmacologist.
After graduating in Pharmaceutical Chemistry and Technology (MPharm equivalent), she obtained a PhD in neuroscience in Italy with a thesis on the neuropharmacology of antidepressants. Subsequently, she worked on the neuropharmacology of drug addiction as postdoctoral researcher at the centre for health and medical research INSERM in Bordeaux (France). After successful qualification to work as Clinical Research Associate, she led a study on metabolic and sleep disturbances in people with Huntington’s Disease, at the Cambridge University Hospital.
She then became a Lecturer at ARU in 2015, and Senior Lecturer in 2016. She has won two VC PhD studentships while at ARU.
Francesca areas of expertise are in Neuroscience, Pharmacology, Drug Addiction, Cognitive Neuroscience, Sleep, Electrophysiology. She is more specifically interested in:
BSc (Hons) Biomedical Science:
Aparício C., Panin F., 2021. The Intervention of Digital Noise Display Reduces Noise Levels and Raises Staff’s Awareness in Hospital Ward. A Qualitative Literature Review. J. Healthc. Manag. In press.
Aparício C., Panin F. Interventions to improve inpatients' sleep quality in intensive care units and acute wards: a literature review. Br J Nurs. 2020 Jul 9;29(13):770-776. doi: 10.12968/bjon.2020.29.13.770.
Panin, F., Peana, A. T., 2019. Sleep and the pharmacotherapy of alcohol use disorder: unfortunate bedfellows. A systematic review with meta-analysis. Frontiers in Pharmacology, 17(10), p. 1164. doi: 10.3389/fphar.2019.01164
Collins, L. M., Begeti, F., Panin, F., Lazar, A. S., Cruickshank, T., Ziman, M., Mason, S. L., Barker, R. A., 2015. Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington's Disease. PLoS Current, 7. PMCID: PMC4570842.
Panin F.*, Lazar A. S.*, Goodman A. O., Lazic S. E., Lazar Z. I., Mason S. L., Rogers L., Murgatroyd P. R., Watson L. P., Singh P., Borowsky B., Shneerson J. M., Barker R. A., 2015. Sleep deficits but no metabolic deficits in premanifest Huntington's disease. Annals of Neurology, 78(4), pp. 630-48.
Panin, F., Lintas, A., Diana, M., 2014. Nicotine-induced increase of dopaminergic mesoaccumbal neuron activity is prevented by acute restraint stress. In vivo electrophysiology in rats. Eur Neuropsychopharmacology, 24, pp.1175-1180.
Vallée, M., Vitiello, S., Bellocchio, L., Hébert-Chatelain, E., Monlezun, S., Martin-Garcia, E., Kasanetz, F., Baillie, G. L., Panin, F., Cathala, A., Roullot-Lacarrière, V., Fabre, S., Hurst, D. P., Lynch, D. L., Shore, D. M., Deroche-Gamonet, V., Spampinato, U., Revest, J. M., Maldonado, R., Reggio, P. H., Ross, R. A., Marsicano, G., Piazza, P. V., 2014. Pregnenolone can protect the brain from cannabis intoxication. Science, 343, pp.94-98.
Panin, F., Cathala, A., Piazza, P. V., Spampinato, U., 2012. Coupled intracerebral microdialysis and electrophysiology for the assessment of dopamine neuron function in vivo. Journal of Pharmacological and Toxicological Methods, 65, pp.83-92.